View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Metals Acquisition Ltd: 1 director

A director at Metals Acquisition Ltd maiden bought 20,079 shares at 12.450USD and the significance rating of the trade was 82/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last t...

 PRESS RELEASE

Alchip Showed Advanced Process & Packaging Technology at TSMC Technolo...

Alchip Showed Advanced Process & Packaging Technology at TSMC Technology Symposiums San Jose, CA, May 07, 2024 (GLOBE NEWSWIRE) -- Alchip Technologies, Ltd. the high-performance ASIC leader, highlighted its recent accomplishments and future direction at its TSMC’s 2024 Technology Symposium exhibit in Santa Clara, CA, and Workshop in Austin, TX. Central to its theme were its advanced technology, and chiplet design plans. Alchip will also be present at TSMC NA Technology Workshops in Boston, MA, as well as Technology Symposiums in Europe, Taiwan, China, and Japan. At its booth, Alchip f...

 PRESS RELEASE

X4 Pharmaceuticals Reports First-Quarter 2024 Financial Results and Pr...

X4 Pharmaceuticals Reports First-Quarter 2024 Financial Results and Provides Corporate Updates U.S. launch underway for XOLREMDI™ (mavorixafor) in WHIM syndrome XOLREMDI Phase 3 4WHIM clinical trial data published online in Blood, the journal of the American Society of Hematology Presentation of interim clinical data from the ongoing mavorixafor Phase 2 trial in chronic neutropenia expected at a planned company investor event in June 2024 Conference call to be hosted today at 8:30 a.m. ET BOSTON, May 07, 2024 (GLOBE NEWSWIRE) -- (Nasdaq...

 PRESS RELEASE

Radware Only Vendor to Receive a Top Score for AI-Enhanced Vulnerabili...

Radware Only Vendor to Receive a Top Score for AI-Enhanced Vulnerability Detection in New GigaOm Report Ranked as a leader in application and API security MAHWAH, N.J., May 07, 2024 (GLOBE NEWSWIRE) -- ® (NASDAQ: RDWR), a leading provider of cyber security and application delivery solutions, today announced that GigaOm has ranked Radware as a Leader and Fast Mover in GigaOm’s 2024 Radar for Application and (AAS) Report. Radware is the only vendor among the 13 security providers evaluated in the report to earn a top score for AI-enhanced vulnerability detection. In addition, Radware rec...

 PRESS RELEASE

Atkore Inc. Announces Second Quarter 2024 Results

HARVEY, Ill.--(BUSINESS WIRE)-- Atkore Inc. (the “Company” or “Atkore”) (NYSE: ATKR) announced earnings for its fiscal 2024 second quarter ended March 29, 2024. “Atkore achieved solid results in the second quarter having met our projections for Net Sales and exceeding our projections for Adjusted EBITDA and Adjusted Diluted EPS we presented in February,” said Bill Waltz, Atkore President and Chief Executive Officer. “Organic volume grew 6% for the first half of the year while down 1% for the second quarter. We continue to execute our capital deployment model by investing in our business and ...

 PRESS RELEASE

Esperion Reports First Quarter 2024 Financial Results

Esperion Reports First Quarter 2024 Financial Results – Q1 Total Revenue Grew 467% Y/Y to $137.7 Million, Reflecting Strong Growth Globally – – Q1 U.S. Net Product Revenue Grew 46% Y/Y to $24.8 Million – – Q1 Retail Prescription Equivalents Grew 43% Y/Y and 6% Q/Q, Increased Momentum from Label Expansions Expected Throughout 2024 – – Received U.S. FDA Approval of Broad New Label Expansions for NEXLETOL® (bempedoic acid) Tablet and NEXLIZET® (bempedoic acid and ezetimibe) Tablet, Becoming the First LDL-C Lowering Non-Statins to Prevent Heart Attacks and Reduce Cardiovascular Risk in Prima...

 PRESS RELEASE

Fractyl Health to Report First Quarter 2024 Financial Results and Prov...

Fractyl Health to Report First Quarter 2024 Financial Results and Provide Business Updates on May 13, 2024 BURLINGTON, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company”), a metabolic therapeutics company focused on pioneering new approaches for the treatment of obesity and type 2 diabetes (T2D), today announced it will report financial results for the first quarter 2024 and provide business updates after market close on Monday, May 13, 2024. The Company’s management will host a conference call on the same day beginning at 4:30 p.m. ET. A live webc...

 PRESS RELEASE

Calfrac Reports First Quarter 2024 Results

Calfrac Reports First Quarter 2024 Results CALGARY, Alberta, May 07, 2024 (GLOBE NEWSWIRE) -- Calfrac Well Services Ltd. (“Calfrac” or “the Company”) (TSX: CFW) announces its financial and operating results for the three months ended March 31, 2024. The following press release should be read in conjunction with the management’s discussion and analysis and interim consolidated financial statements and notes thereto as at March 31, 2024. Readers should also refer to the “Forward-looking statements” legal advisory and the section regarding “Non-GAAP Measures” at the end of this press release...

 PRESS RELEASE

Sun Country Airlines Reports First Quarter 2024 Results

Sun Country Airlines Reports First Quarter 2024 Results Revenue of $311 million, highest first quarter on record(1)GAAP diluted EPS of $0.64 and operating income of $55 millionAdj. diluted EPS(2) of $0.66 and adjusted operating income(2) of $57 million, MINNEAPOLIS, May 07, 2024 (GLOBE NEWSWIRE) -- Sun Country Airlines Holdings, Inc. (“Sun Country Airlines,” “Sun Country,” the “Company”) () today reported financial results for its first quarter ended March 31, 2024. “Sun Country’s diversified business model produced another strong first quarter with margins that we expect to finish at t...

 PRESS RELEASE

MediciNova Receives Issue Notification for New Patent Covering Extende...

MediciNova Receives Issue Notification for New Patent Covering Extended-Release Formulations of MN-166 (ibudilast) LA JOLLA, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that it has received an issue notification from the U.S. Patent and Trademark Office for a new patent which covers extended-release oral formulations of MN-166 (ibudilast). This new patent is expected to expire no earlier than September 2040. Th...

 PRESS RELEASE

Calibre to Provide an Update on the Valentine Gold Mine and Host Its F...

Calibre to Provide an Update on the Valentine Gold Mine and Host Its First Quarter 2024 Financial Results Conference Call on Wednesday, May 15, 2024 VANCOUVER, British Columbia, May 07, 2024 (GLOBE NEWSWIRE) -- Calibre (TSX: CXB; OTCQX: CXBMF) (“Calibre” or the “Company”) will provide an update on its 100% owned, fully funded Valentine Gold Mine located in Newfoundland & Labrador, Canada on Wednesday May 15, 2024. Valentine remains on track to reach production during H1, 2025. In addition, the Company will release its first quarter 2024 financial results on Tuesday, May 14, 2024 after the...

 PRESS RELEASE

Immuron Limited to Present at the Emerging Growth Conference

Immuron Limited to Present at the Emerging Growth Conference MELBOURNE, Australia, May 07, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to invite individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference, on Wednesday 8th May. The next Emerging Growth Conference will be presented on Wednesday, 8 May, 2024. This live, interactive online event will give existing shareholders and the investme...

 PRESS RELEASE

Aurinia Will Attend 2024 RBC Capital Markets Global Healthcare Confere...

ROCKVILLE, Md. & EDMONTON, Alberta--(BUSINESS WIRE)-- Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that it will attend the 2024 RBC Capital Markets Global Healthcare Conference in New York from May 14-15, 2024. Aurinia management will host one-on-one meetings with investors and will participate in a fireside chat on Wednesday, May 15, from 10:00 to 10:25 AM Eastern Time. A live webcast of the session will be available on the Investor section of Aurinia’s website, which can be found About Aurinia Aurinia Pharmaceuticals is a fully integrated biopharm...

 PRESS RELEASE

Ændret finanskalender

Ændret finanskalender Nasdaq First North Growth Market DenmarkSelskabsmeddelelse nr. 66/2024                                                Odense, 7. maj 2024 Ændret finanskalender I henhold til Selskabets finanskalender for 2024 skulle selskabets årsrapport for 2023 offentliggøres i morgen den 8. maj 2024. Udarbejdelse og revision af årsrapporten har desværre taget længere tid end forventet og er endnu ikke klar. Der henvises i den forbindelse til den tidligere udsendte Selskabsmeddelelse nr. 65/2024 af dags dato. Årsrapporten for 2023 vil i stedet blive offentliggjort den 15. maj 20...

Altria Group Inc: 1 director

A director at Altria Group Inc sold 22,487 shares at 43.953USD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...

Propetro Holding Corp: 1 director

A director at Propetro Holding Corp sold 42,573 shares at 9.280USD and the significance rating of the trade was 66/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...

 PRESS RELEASE

Children from Wuzhishan, Hainan Sings on the Seine in Paris during the...

EQS Newswire / 07/05/2024 / 11:45 CET/CEST PARIS, FRANCE - - 7 May 2024 - On 4th May, the Chinese-French Cultural Exchange Delegation of Wuzhishan City, Hainan Province, together with the Wuzhishan City Li & Miao Children's Choir, sang "Wuzhishan resounds through France" through a bilingual Chinese-French rendition, bringing wishes from China into Paris, France. During the event, surrounded by flowers, nice food and the flowing river, the choir's melodious singing floated over the Seine. "The fire under the snowy mountains, is as shining as the sunshine in the rainforest. The fine wine ...

 PRESS RELEASE

Highest Performances Holdings Inc. (NASDAQ: HPH) Increases Its Shareho...

Highest Performances Holdings Inc. (NASDAQ: HPH) Increases Its Shareholding in Fanhua to 51.1% GUANGZHOU, China, May 07, 2024 (GLOBE NEWSWIRE) -- Highest Performances Holdings Inc. (NASDAQ: HPH) (“HPH” or the “Company”), today announced that it has increased its shareholding in Fanhua Inc. (“Fanhua”), a leading technology-driven independent financial service provider in China, from 50.1% to 51.1% as of May 6, 2024 by acquiring 565,000 American Depositary Shares of Fanhua on Nasdaq. Mr. Yinan Hu, Vice Chairman and CEO of HPH commented, “We are pleased to witness the solid progress that ...

Harmonic Inc: 1 director

A director at Harmonic Inc sold 52,730 shares at 10.951USD and the significance rating of the trade was 76/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...

 PRESS RELEASE

Bestyrelsen i Scape Technologies A/S foreslår afnotering fra Nasdaq Fi...

Bestyrelsen i Scape Technologies A/S foreslår afnotering fra Nasdaq First North Growth Market Denmark Nasdaq First North Growth Market DenmarkSelskabsmeddelelse nr. 65/2024                                                Odense, 7. maj 2024*Indeholder intern viden* Bestyrelsen i Scape Technologies A/S foreslår afnotering fra Nasdaq First North Growth Market Denmark Bestyrelsen i Scape Technologies A/S (“Selskabet”) har besluttet at stille forslag på Selskabets ordinære generalforsamling i maj 2024 om afnotering af Selskabets aktier fra Nasdaq First North Growth Market Denmark. Generalfo...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch